Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 micrograms per milliliter in MGIT
dc.contributor.author | Whitfield, Michael G. | en_ZA |
dc.contributor.author | Warren, Robin M. | en_ZA |
dc.contributor.author | Streicher, Elizabeth M. | en_ZA |
dc.contributor.author | Sampson, Samantha L. | en_ZA |
dc.contributor.author | Sirgel, Frik A. | en_ZA |
dc.contributor.author | Van Helden, Paul D. | en_ZA |
dc.contributor.author | Mercante, Alexandra | en_ZA |
dc.contributor.author | Willby, Melisa | en_ZA |
dc.contributor.author | Hughes, Kelsey | en_ZA |
dc.contributor.author | Birkness, Kris | en_ZA |
dc.contributor.author | Morlock, Glenm | en_ZA |
dc.contributor.author | Van Rie, Annelies | en_ZA |
dc.contributor.author | Posey, James E. | en_ZA |
dc.date.accessioned | 2016-10-06T07:23:57Z | |
dc.date.available | 2016-10-06T07:23:57Z | |
dc.date.issued | 2015 | |
dc.description | CITATION: Whitfield, M. G. et al. 2015. Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 micrograms per milliliter in MGIT. Journal of Clinical Microbiology, 53:3633–3635, doi:10.1128/JCM.01001-15. | |
dc.description | The original publication is available at http://jcm.asm.org | |
dc.description.abstract | Sequencing of the Mycobacterium tuberculosis pncA gene allows for pyrazinamide susceptibility testing. We summarize data on pncA polymorphisms that do not confer resistance at a susceptibility breakpoint of 100 μg/ml pyrazinamide in MGIT within a cohort of isolates from South Africa and the U.S. Centers for Disease Control and Prevention. | en_ZA |
dc.description.uri | http://jcm.asm.org/content/53/11/3633.abstract?sid=13f06819-4c59-4a74-b9d4-420336a00b30 | |
dc.description.version | Publisher's version | |
dc.format.extent | 3 pages | |
dc.identifier.citation | Whitfield, M. G. et al. 2015. Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 micrograms per milliliter in MGIT. Journal of Clinical Microbiology, 53:3633–3635, doi:10.1128/JCM.01001-15. | |
dc.identifier.issn | 1098-660X (online) | |
dc.identifier.issn | 0095-1137 (print) | |
dc.identifier.other | doi:10.1128/JCM.01001-15 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/99699 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | American Society for Microbiology | |
dc.rights.holder | American Society for Microbiology | |
dc.subject | Mycobacterium tuberculosis pncA -- Immunological aspects | en_ZA |
dc.subject | Genetic polymorphisms | en_ZA |
dc.subject | Pyrazinamide susceptibility | en_ZA |
dc.subject | Drug resistance | en_ZA |
dc.subject | Sequencing | en_ZA |
dc.title | Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 micrograms per milliliter in MGIT | en_ZA |
dc.type | Article | en_ZA |